title: Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
authors.affiliation: Department of Psychological Medicine, King's College London, UK. silje.reme@uib.no
authors.forename: Silje Endresen
authors.initials: SE
authors.lastname: Reme
authors.forename: Tom
authors.initials: T
authors.lastname: Kennedy
authors.forename: Roger
authors.initials: R
authors.lastname: Jones
authors.forename: Simon
authors.initials: S
authors.lastname: Darnley
authors.forename: Trudie
authors.initials: T
authors.lastname: Chalder
mesh_terms: D000293:Adolescent; D000328:Adult; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy / Q000523:psychology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D011320:Primary Health Care / Q000706:statistics & numerical data*; D011446:Prospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D010276:Parasympatholytics; D010627:Phenethylamines; C005096:mebeverine